Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
00966 CHINA TAIPING
RTNominal down9.390 -0.060 (-0.635%)
Others

14/02/2019 14:02

[I-bank focus]Critical illness insurance seen growth driver

[ET Net News Agency, 14 February 2019] Daiwa Research expects critical illness
insurance to be the key growth driver for the broad China insurance market not only for
2019 but also for years ahead.
The research house forecast the market size to record a 20-24% CAGR over 2018-22.
Daiwa said China will see 357m urban households, of which 63% will be
middle-class-and-above households, by 2022. Assuming 35% of these households and 2
policies per household, it calculated 157m critical illness insurance customers.
On another scenario, it estimated China's total health expenditure inflation to rise at
a 12% CAGR and health insurance to grow at a 20% CAGR over 2016-30.
Daiwa also believes China's GDP growth (assuming 8% until 2030 in nominal terms) will
prompt a higher insurance contribution to total non-public health expenditure, which is
forecast to be 26% in 2030. This approach yields a 20% CAGR in commercial health insurance
over 2016-30.
Hence, it reiterated its "positive" sector stance. (KL)

Remark: Real time quote last updated: 17/09/2024 17:59
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2024 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.